DENVER INVESTMENT ADVISORS LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 2.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
DENVER INVESTMENT ADVISORS LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2018$41,000
-12.8%
13,846
-18.7%
0.00%0.0%
Q4 2017$47,000
-19.0%
17,0290.0%0.00%
-33.3%
Q3 2017$58,000
+52.6%
17,029
+48.7%
0.00%
+50.0%
Q3 2016$38,000
-2.6%
11,453
-6.7%
0.00%0.0%
Q2 2016$39,000
-20.4%
12,275
-17.3%
0.00%0.0%
Q1 2016$49,000
-29.0%
14,849
-24.0%
0.00%
-33.3%
Q4 2015$69,00019,5500.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2016
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders